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The transcriptional enhancer of the Moloney Murine Leukemia virus (MO-MuLV) is comprised of a 75-bp direct repeat, each of which contains 
multiple binding sites for transcription factors. The occupancy of these sites determines the tissue specificity of expression and disease tropism 
of the virus. The identification of proteins that bind to this enhancer is therefore required in order to understand the mol~ular basis of this viral- 
host interaction. Analysis of the nucleic acid sequence of the MO-MuLV has identified 4 potential binding sites for the transcription factor NF-1. 
Evidence is presented using DNase I protection analysis that NF-1 binds to these 4 sites within the enhancer. The potential role of NF-1 binding 
in tissue specific expression of MO-MuLV is discussed. 
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1. INTRODUCTION 
The Moloney Murine leukemia virus (MO-MuLV) 
contains a transcriptional enhancer within the U3 
region of the long terminal repeat (LTR) that is com- 
prised of a 75-bp repeated sequence located approx- 
imately 160 bp 5 ’ to the initiation site of transcription 
[l]. This transcriptional enhancer controls the tissue 
specific expression of the LTR [1,2,3,4] and contains 
the primary genetic determinants of the Ieukemogenici- 
ty and disease specificity of the virus [5,6]. 
Like other viral and cellular transcriptional en- 
hancers, the MO-MuLV enhancer is composed of mul- 
tiple binding sites for cellular transcription factors 
[7,8]. The array of transcription factors that bind to 
these sequences in different cell types presumably 
regulates the activity of the LTR and thus the oncogenic 
potential of the virus [6,9]. The identification and 
characterization of these subunits of the viral enhancer 
and the cellular factors that interact with them are 
therefore essential towards generating an understanding 
of the basis of this virus-host interaction. 
enhancer contains two non-identical copies of se- 
quences highly homologous to the consensus NF-1 bin- 
ding site (5 ’ -TGGA/C NsGCCAA [lo]). These poten- 
tial NF-1 sites have been highly conserved among 
murine leukemia viruses [ 11,121 and thus are likely to be 
functionally important for expression of viral genes. 
While mutations in these sites have been shown to 
decrease the activity of the enhancer [9], direct binding 
of NF-1 to the LTR has not been demonstrated. Here I 
present biochemist evidence showing that these NF-1 
sites specifically bind protein present in HeLa cell 
nuclear extracts. Furthermore, affinity-purified NF-1 
derived from HeLa cells binds to the same 4 sites in the 
enhancer demonstrating directly that NF-1 binds to the 
MO-MuLV transcriptional enhancer. 
2. EXPERIMENTAL 
Previous studies have identified binding sites for at 
least 6 cellular factors within each 75”bp element of the 
MO-MuLV enhancer. These include binding sites for 
leukemia virus factors a, b, and c (LVa, LVb and LVc), 
the CCAAT/enhan~er-binding protein (C/EBP), the 
glu~ocorticoid response element (GRE) as well as 
potential binding sites for the transcription factor 
nuclear factor-l (NF-1) [7]. With respect to NF-1 bin- 
ding, each copy of 75-bp repeat of the MO-MuLV 
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Nuclear extracts of HeLa cells were prepared essentially by the 
method of Dignam et al. [13]. The crude nuclear extract was subjected 
to heparin-agarose chromatography and fractions eluting between 
0.15 M and 0.4 M KC1 were collected and used for binding reactions. 
HeLa heparin-agarose fractions were kindly provided by Dr J. 
Nyborg (Colorado State University, Ft. Collins). NF-1 was purified 
from HeLa nuclear extracts by DNA-affinity chromatography 1141 
and was a gift from Dr R. Markowitz (University of Colorado, 
Boulder). 
A 470-bp C/al-Xbal restriction fragment (positions 7676-8116) 
[15] from the U3 region of the MO-MuLV LTR was subcloned into 
pucl9 at the Smal site of the polylinker. The fragment was released 
from the vector by digestion with EcoRI and HindIII. The DNA pro- 
be was 5’-end labeled on either the non-coding or coding strands by 
reaction with [y-‘2P]ATP and polynucleotide kinase or by reaction 
with [o-32P]dATP followed by digestion at the BarnHI site of the 
polylinker to release s2P incorporated at one end of the molecule. Bin- 
ding reactions for DNase I protection analysis contained 10 fmol “P- 
labeled DNA, 1 fig poly(dl-dC), 25 mM Tris-HCl (pH 7,5), 0.5 M ED- 
TA, 1 mM DTT, 50 mM KCI, 6.25 mM MgC12 and 10% glycerol in 
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Fig. 1. Organization of the U3 region of the MO-MuLV LTR. Sequences are from the 3’ end of a MO-MuLV provirus extending from the C/al 
site (7676) in the env gene to the start site of transcription (arrow at 8265) [15]. The TATA and CAAT boxes lie upstream to the transcription start 
site. The transcriptional enhancer is comprised of a 75-bp perfect direct repeat (boxed arrows). The nucleotide sequence of one copy of the direct 
repeat is shown. The reported binding sites for nuclear factors [7] are underlined. 
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a final reaction volume of 50~1. Binding reactions were carried out on 
ice for 15 min, treated with DNase I (0.2 to 2pg/ml), extracted with 
phenol/CHCls 1: 1 and electrophoresed in 7% acrylamide/8 M urea 
sequencing gels. Maxam-Gilbert sequencing reactions were run in ad- 
jacent lanes for DNA sequence positions. 
3. RESULTS AND DISCUSSION 
The organization of the U3 region of the MO-MuLV 
LTR is shown in Fig. 1. The predicted NF-1 binding 
sites [7] map to the 75bp direct repeat and occur at 
identical positions within each repeat. NF-1 site ‘a’ 
maps to positions 7939-7952 and 80148027 and NF-1 
site ‘b’ maps to positions 7984-7997 and 8059-8072. To 
determine whether these sites interact with nuclear pro- 
teins, DNA containing the 75-bp repeat (between posi- 
tions 7676 and 8116) was end-labeled with 32P at posi- 
tion 8116 and analyzed by DNase I protection analysis 
using heparin-agarose chromatography fractions of 
nuclear extracts from HeLa cells. As shown in Fig. 2, 
two regions of each copy of the 75-bp repeat are pro- 
tected from DNase I digestion indicating that nuclear 
proteins are binding to these sites. The four protected 
regions span positions 7933-7958, 7980-8005, 
8008-8033 and 8055-8080. Each of these regions con- 
tains within it the predicted NF-1 binding site. 
Since the regions of protection are quite large (-25 
bp) and contain within them other potential binding 
sites, nuclear DNA binding proteins other than NF-1 
could be responsible for this pattern of protection over 
the 75-bp repeat. This question was addressed by assay- 
ing for NF-1 binding using purified NF-1 in the DNase 
Fig. 2. DNase I protection analysis of the MO-MuLV transcriptional 
enhancer. Binding reactions were carried out with a 470-bp 
CfaI-XbaI fragment that was “P-labeled at either the coding (A) or 
non-coding (B) strand 35 bp 3’ to the enhancer at the XbaI site (see 
Fig. 1). The DNA was incubated in the absence (0) or presence (15 fig) 
of heparin-agarose enriched HeLa nuclear extract. Regions of protec- 
tion are bracketed with the numbers of the corresponding nucleotide 
sequence. The positions of the sequences were determined by Max- 
am-Gilbert sequencing reactions. 
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Fig. 3. DNase I protection analysis of the MO-MuLV transcriptional 
enhancer after incubation with affinity purified NF-1 (IO and 15 pl, 
corresponding to 0.3 and 0.45 ,ug of protein, respectively). Control 
lanes (0) contained no added protein. Protected regions on the non- 
coding strand are indicated by brackets along with the numbers of the 
corresponding nucleotide sequence. ‘a’ and ‘b’ refer to the putative 
NF-1 binding sites first identified by Speck and Baltimore [7]. 
I protection assay. As demonstrated in Fig. 3, purified 
NF-1 was found to bind within the 75bp repeat to the 
same 4 sites observed with Wela cell extracts. The NF-1 
sites, labeled ‘a’ and ‘b’ occur at positions 7932-7952, 
8007-8028 and 7976-8~, 805 l-8074, respectively. All 
these sites show a high degree of homology to the NF-1 
consensus binding site 17, lo]. 
In summary, the data presented here demonstrate 
that NF-1 binds to 4 positions within the transcriptional 
enhancer of MO-MuLV. This result together with 
previous results showing that mutations in either the 
NF-lb or both the NF-la and b binding sites lead to a 
preferential decrease in promoter activity in fibroblasts 
but not lymphoid cells [9] indicate that NF-1 binding 
may play a role in cell type specific expression of the 
LTR. NF-I has been shown to comprise of a family of 
polypeptides that are active in transcriptional activation 
which are encoded by multiple species of mRNAs 
116,171. It has been proposed that different cell types 
may encode different subsets of NF-1 having altered ac- 
tivities or binding specificities [17]. Thus the array of 
NF-1 proteins in the nucIeus could potentially alter the 
expression of the LTR. In addition, the presence of 
other nuclear factors that bind to nearby or overlapping 
sites and thus compete with NF-1 for binding may also 
play an important role in regulating expression from the 
LTR. Further studies will determine the relationship of 
cell type specific NF-1 species having varied activities or 
affinities for different binding sites in the enhancer to 
the cell type specific expression and disease tropism of 
MO-MuLV. 
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